Acknowledgement
이 성과는 정부(과학기술보통신부)의 재원으로 한국연구재단의 지원을 받아 수행된 연구임(No. 2021R1F1A1047437).
References
- Myung HJ, Lee SB, Rho JK, Yoon BW, Lee WY, Kim MH, et al. Current status of cerebrovascular disease in Korea. J Korean Neurol Assoc. 1989;7(1):179-87.
- Song IH, Oh DH, Kang HS, Choue CW, Kim KS, Kim MS, et al. Changing pattern of stroke during the recent 10 years in Korea. Korean J Med. 1992;43(5):637-45.
- Kim JK, Seol IC, Lee I, Jo HK, Yu BC, Choi SM. Report on the Korean standard differentiation of the symptoms and signs for the stroke-1. J Physiol & Pathol Korean Med. 2006;20(1):229-34.
- Statistics Korea. Cause of death 2021. Available from URL; https://kostat.go.kr/board.es?mid=a10301060200&bid=218&act=view&list_no=420715 (accessed 2023-05-23).
- Ko S, Jeong Y, Kim D. The social burden and care management for people with dementia. Korea Institute for Health and Social Affairs. Sejong-si: 2016:15-80.
- Statistics Korea(KOSIS). Stroke patients (by sex, age, and month) 2023. Available from URL; https://kosis.kr/statHtml/statHtml.do?orgId=411&tblId=DT_41104_222 (accessed 2023-05-23).
- Yun YS. A study of symptoms and treatments seeking behavior in acute stroke patients. Yonsei University Graduate School, Thesis of Master Degree. 2005:5-14.
- Jeong J, Moon H. Stroke epidemiology and risk factors in Korea. Medical POSTGRADUATES. 2001;29(2):76-80.
- Cardiovascular Research Center. Acute coronary artery syndrome white paper. 2012:1-7. Available from URL;http://www.bktimes.net/data/board_notice/1329376449-99.pdf (accessed 2023-05-23).
- Park TH. Prevalence of risk factors for ischemic stroke in Korean. J Korean Neurol Assoc. 2009;27(1):19-27.
- Hong YS, Suh MJ, Kim KS, Kim I, Cho NO, Choi HJ, et al. Related factors of the quality of life in stroke patients. Korean J Rehabil Nurs. 1998;1(1):111-23.
- Kim K, Leigh J, Oh BM, Jung SH, Lee KM, Park SW, et al. The cost of brain disorder: Individual and social cost. Brain & NeuroRehabilitation. 2010;3(2):86-93. https://doi.org/10.12786/bn.2010.3.2.86
- Kim CG, Park HA. Development and evaluation of a web-based education program to prevent secondary stroke. J Korean Acad Nurs. 2011;41(1):47-60. https://doi.org/10.4040/jkan.2011.41.1.47
- Kwin JH. Surgical management of acute stroke. J Korean Med Assoc. 2009;52(4):375-81. https://doi.org/10.5124/jkma.2009.52.4.375
- Chugh C. Acute ischemic stroke; Management approach. Indian J Crit Care Med. 2019:23(Suppl 2): S140-6. https://doi.org/10.5005/jp-journals-10071-23192
- Bansal S, Sangha KS, Khatri P. Drug treatment of acute ischemic stroke. Am J Cardiovasc Drugs. 2013;13(1):57-69. https://doi.org/10.1007/s40256-013-0007-6
- Lee MH, Park HS, Choi WC. The effects of herb extracts in cerebrovascular accidental patient. Korean J Rehabil Nurs. 2000;3(2):141-53.
- Kuriakose D, Xiao Z. Pathophysiology and treatment of stroke: Present status and future perspectives. Int J Mol Sci. 2020;21(20):7609.
- Kim JH. The study on the selection of Sasang Constitution-specific herbs in 「Dongyisusebowon Sinchuk-Bon」 from TCMID and TCMSP. J Sasang Constitut Med. 2019;31(3):19-33.
- Lee SE, Lim JY, Chung BW, Lee B, Lim JH, Cho S. Network pharmacological analysis for exploration of the potential application of Hwangryunhaedoktang for brain diseases. Herb Formula Sci. 2020;28(4):313-25.
- Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6(13):Available from URL: https://doi.org/10.1186/1758-2946-6-13.
- Han SY, Kim YK. New approach for herbal formula research; Network pharmacology. J Physiol & Pathol Korean Med. 2016;30(6):385-96. https://doi.org/10.15188/kjopp.2016.12.30.6.385
- Lee WY, Kim CE, Lee CY. A novel method to investigating Korean Medicine theory drug-centered approach employing network pharmacology. J Physiol & Pathol Korean Med. 2021;35(5):125-31. https://doi.org/10.15188/kjopp.2021.10.35.5.125
- Kim IR. A Research on the origin and daily dose of Gardeniae Fructus in Shanghanlun. Kor J Herbology. 2011;26(4):155-61.
- Xiao W, Li S, Wang S, Ho CT. Chemistry and bioactivity of Gardenia jasminoides. J Food Drug Anal. 2017;25(1):43-61. https://doi.org/10.1016/j.jfda.2016.11.005
- Song JS, Shin JE, Kim JH, Kin YH. Gardenia jasminoides exerts anti-inflammatory activity via Akt and p38-dependent heme oxygenase-1 upregulation in microglial cells. J Life Sci. 2017;27(1):8-14. https://doi.org/10.5352/JLS.2017.27.1.8
- Han YN, Oh HK, Hwang KH, Lee MS. Antioxidant components of gardenia fruit. Korean J Pharmacogn. 1994;25(3):226-32.
- Ni Y, Li L, Zhang W, Lu D, Zang C, Zhang D, et al. Discovery and LC-MS characterization of new crocins in Gardeniae Fructus and their neuroprotective potential. J Agric Food Chem. 2017;65(14):2936-46. https://doi.org/10.1021/acs.jafc.6b03866
- Toriizuka K, Kamiki H, Ohmura NY, Fujii M, Hori Y, Fukumura M, et al. Anxiolytic effect of Gardeniae Fructus-extract containing active ingredient from Kamishoyosan (KSS), a Japanese traditional Kampo medicine. Life Sci. 2005;77(24):3010-20. https://doi.org/10.1016/j.lfs.2004.12.054
- Arner P, Hoffstedt J. Adrenoceptor genes in human obesity. J Intern Med. 1999;245(6):667-72. https://doi.org/10.1046/j.1365-2796.1999.00495.x
- Noh H, Yu MR, Kim HJ, Lee JH, Park BW, Wu IH, et al. Beta 2-adrenergic receptor agonists are novel regulators of macrophage activation in diabetic renal and cardiovascular complications. Kidney Int. 2017;92(1):101-13. https://doi.org/10.1016/j.kint.2017.02.013
- Bae JS, Kang BY, Kim KT, Shin JH, Lee CC. Association study on the genetic variation of the dopamine D1 receptor gene in Korean essential hypertensives. Genes & Genomics. 2001;23(3):221-6.
- Choi JH, Park KW, Park YB, Oh BH, Kim HS, Zhang SY, et al. The Association between the T102C polymorphism of the HTR2A serotonin receptor gene and HDL cholesterol level in Koreans. BMB reports. 2005;38(2):238-42. https://doi.org/10.5483/BMBRep.2005.38.2.238
- Lee HJ, Kwak SK, Paik JW, Kang RH, Lee MS. Association between serotonin 2A receptor gene polymorphism and posttraumatic stress disorder. Psychiatry Investig. 2007;4:104-8.
- Cho BPH, Jolly AA, Nannoni S, Tozer D, Bell S, Markus HS. Association of NOTCH3 variant position with stroke onset and other clinical features among patients with CADASIL. Neurology. 2022;99(5):e430-9. https://doi.org/10.1212/WNL.0000000000200744
- Chang JW, Coleman PD, O'Banion MK. Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease. Neurobiol Aging. 1996;17(5):801-8. https://doi.org/10.1016/0197-4580(96)00110-8
- Lei Y, Hu L, Yang G, Piao L, Jin M, Cheng X. Dipeptidyl peptidase-IV inhibition for the treatment of cardiovascular disease - Recent insights focusing on angiogenesis and neovascularization. Circ J. 2017;81(6):770-6. https://doi.org/10.1253/circj.CJ-16-1326